Shape strategic responses through the phases of industry recovery. Boehringer Ingelheim International GmbH, Catalent Inc., and Icon Plc. will emerge as major pharmaceutical contract research and manufacturing market participants during 2020-2024. The pharmaceutical contract research and manufacturing market are expected to grow by USD 69.09 billion during 2020-2024, according to Technavio.
RALEIGH, N.C., Jan. 20, 2021 After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide. Since 2011, RMA has provided a variety of clinical research marketing services across a broad range of therapeutic areas.
LONDON, Jan. 20, 2021 According to a new market research report, titled "In-vitro Diagnostics Market by Product & Solution, Technology, Application, End UserForecast to 2027", published by Meticulous Research®, the in-vitro diagnostics market is expected to register a CAGR of 7% from 2020 to 2027 to reach $118.5 billion by 2027.
NEW YORK, Jan. 20, 2021 Serum-free media gives more consistent cell growth and helps eliminate possible errors by minimizing the percentage of uneven growth among cell cultures. Increasing focus on biopharmaceuticals to treat chronic diseases is fuelling biopharmaceutical production.
SAN FRANCISCO, Jan. 19, 2021 The global laboratory proficiency testing market size is expected to reach USD 1.9 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.3% from 2020 to 2027. Government initiatives to carry out accurate and reliable proficiency testing are expected to drive the market.
SARASOTA, Fla. Manufacturers seeking the FDA's GMP certification must meet strict guidelines in order to demonstrate manufacturing cleanliness, process controls, product consistency, employee and consumer safety, and product traceability.
PRINCETON, N.J., Jan. 13, 2021 Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA, a Clinical Research Organization & technology services company. "We are excited to partner with Bioclinica. Bioclinica's industry leading IRT solution supports any randomization and inventory management requirements.
CAMBRIDGE, Mass., and SOUTH SAN FRANCISCO, Calif., and REDMOND, Wash., Jan. 11, 2021 On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet company, and Microsoft Corp. announced a strategic partnership to accelerate new innovations in biomedicine through the Terra platform.
Precision BioSciences, Inc. (DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced the closing of its in vivo gene editing research collaboration and exclusive license agreement with Eli Lilly and Company following clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
Certis Oncology Solutions, a precision oncology and translational sciences company, announced it will make available its personalized approach to drug efficacy testing to the commercial pharmaceutical industry. This press release features multimedia. More than half of all new cancer drugs fail in clinical trials due to problems with efficacy, said Peter Ellman, Certis Oncology CEO.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
